Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Daunorubicin (liposomal)

EU orphan designation number: EU/3/08/585   
Active ingredient: Daunorubicin (liposomal)
Indication: Treatment of acute myeloid leukaemia
Sponsor: Diatos S. A.
11 rue Watt, 2nd floor, 75013 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
5/12/2008 Orphan designation EMEA/OD/048/08 (2008)8091 of 3/12/2008